Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Heart Failure
Interventions
DRUG

CK-1827452

50 mg MR CK-1827452 BID for 10 days

DRUG

CK-1827452

37.5 mg IR CK-1827452 TID for 10 days

DRUG

CK-1827452

100 mg MR CK-1827452 BID for 10 days

Trial Locations (3)

Unknown

Cardio-Reanimation Centre, Tbilisi

Diagnostic Services Clinic, Tbilisi

Tbilisi State Medical University Clinic #1, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT00941681 - Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure | Biotech Hunter | Biotech Hunter